A report by the self-styled, ‘International Expert Group on Biotechnology, Innovation And Intellectual Property’ says a new era is opening for intellectual property (IP).
The charity Cancer Research UK confirmed its position as the largest single investor in R&D in the field, announcing it spent a record £333 million on research in its last financial year.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.